GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Cyclically Adjusted FCF per Share

Chongqing Lummy Pharmaceutical (SZSE:300006) Cyclically Adjusted FCF per Share : ¥0.05 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chongqing Lummy Pharmaceutical's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.056. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.05 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Chongqing Lummy Pharmaceutical was 43.30% per year. The lowest was 18.90% per year. And the median was 25.30% per year.

As of today (2024-06-12), Chongqing Lummy Pharmaceutical's current stock price is ¥2.50. Chongqing Lummy Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.05. Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is 50.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chongqing Lummy Pharmaceutical was 418.00. The lowest was 48.56. And the median was 188.25.


Chongqing Lummy Pharmaceutical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Cyclically Adjusted FCF per Share Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.08 -0.05 -0.02 0.03

Chongqing Lummy Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.02 0.03 0.05

Competitive Comparison of Chongqing Lummy Pharmaceutical's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF falls into.



Chongqing Lummy Pharmaceutical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chongqing Lummy Pharmaceutical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.056/115.2271*115.2271
=0.056

Current CPI (Mar. 2024) = 115.2271.

Chongqing Lummy Pharmaceutical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.010 98.200 -0.012
201409 -0.035 98.900 -0.041
201412 -0.135 99.000 -0.157
201503 -0.051 99.900 -0.059
201506 -0.002 99.500 -0.002
201509 0.032 100.500 0.037
201512 -0.115 100.600 -0.132
201603 -0.038 102.200 -0.043
201606 0.015 101.400 0.017
201609 -0.017 102.400 -0.019
201612 0.121 102.600 0.136
201703 -0.041 103.200 -0.046
201706 -0.005 103.100 -0.006
201709 0.065 104.100 0.072
201712 0.030 104.500 0.033
201803 -0.018 105.300 -0.020
201806 -0.009 104.900 -0.010
201809 0.059 106.600 0.064
201812 0.091 106.500 0.098
201903 0.003 107.700 0.003
201906 0.056 107.700 0.060
201909 0.037 109.800 0.039
201912 0.113 111.200 0.117
202003 -0.006 112.300 -0.006
202006 0.108 110.400 0.113
202009 0.129 111.700 0.133
202012 -0.008 111.500 -0.008
202103 0.000 112.662 0.000
202106 -0.006 111.769 -0.006
202109 0.047 112.215 0.048
202112 0.025 113.108 0.025
202203 -0.020 114.335 -0.020
202206 -0.060 114.558 -0.060
202209 0.011 115.339 0.011
202212 0.058 115.116 0.058
202303 -0.004 115.116 -0.004
202306 -0.019 114.558 -0.019
202309 0.017 115.339 0.017
202312 0.028 114.781 0.028
202403 0.056 115.227 0.056

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Chongqing Lummy Pharmaceutical  (SZSE:300006) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Chongqing Lummy Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.50/0.05
=50.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chongqing Lummy Pharmaceutical was 418.00. The lowest was 48.56. And the median was 188.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chongqing Lummy Pharmaceutical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical (SZSE:300006) Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical (SZSE:300006) Headlines

No Headlines